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Abstract
This report analyzes the 2006-2010 fetal death files for the state of Ohio by a variety of maternal
and fetal characteristics. The issue of fetal deaths related to congenital anomalies is a growing
concern as very few epidemiologic studies have been conducted in order to assess the correlation
between maternal factors and the development of congenital anomalies. For this study, maternal
demographics, the presence of a congenital anomaly, and maternal risks towards the pregnancy
were analyzed. A Chi-Square analysis to test for variance between fetal deaths with and without
the presence of a congenital anomaly was conducted. The results showed statistical significance
(p < 0.05) between the two populations with respect to maternal age, race, and adequacy of
prenatal care. Women who were over the age of 35 had a 3.3 percent higher rate of fetal deaths
related to congenital anomalies than all other age groups and White women had a higher
percentage of congenital anomalies over African American women. Inadequacy of prenatal care
was associated with 62% of fetal deaths regardless of the association to congenital anomalies.
These findings indicate that our data set follows expected trends for maternal age and adequacy
of prenatal care, but the prevalence of congenital anomalies was centered on the White race. It
was initially expected that the data would show ethical and racial minorities with a high
incidence of fetal deaths and congenital anomalies. The outcomes of this study were limited and
further analysis of a larger data set is recommended.
Keywords: Chi-Square analysis, demographics, race, maternal age
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Fetal Deaths Related to Congenital Anomalies in the State of Ohio: 2006-2010
The issue of fetal deaths is a growing public health concern as very few epidemiologic
studies have indicated that late fetal deaths need to be addressed as a problem. A fetal death can
be simply defined as a death occurring between 8 weeks gestation and birth, but many fetal
deaths go unreported until the mother is past 20 weeks gestation and fetal death rates are largely
underestimated. Because of this, reported fetal death statistics focus on late fetal deaths,
occurring after 20 weeks gestation and before birth. The number of late fetal deaths (20 weeks –
birth) has drastically declined since the mid-twentieth century; however, it is unknown whether
certain characteristics of the mother could possibly contribute to deadly congenital anomalies
(Fretts, Schmittdiel, McLean, Usher, & Goldman, 1995). Studies reviewed by Bell, HertzPicciotto, and Beaumont (2001) have suggested that risk factors for fetal death include smoking,
advanced maternal age, and previous history of fetal death. Advancing maternal age is a proven
risk factor for fetal deaths and women over the age of 35 were shown to have 1.5 higher odds of
fetal deaths than younger women (Fretts et al., 1995). Fetuses affected by maternal preeclampsia or cigarette consumption have shown also to have increased risk of low birth weight
and fetal death late in the pregnancy (Cnattingius, Haglund, & Kramer, 1998). The study by
Cnattingius, Haglund, and Kramer (1998) indicates that smoking and pre-eclampsia can increase
the odds of fetal death by 1.7 to 3.1.
Other risk factors such as twin pregnancies, pregnant women who are shorter than five
feet, and nulliparous (first pregnancy) pregnancies among women over 35 have shown to
increase congenital problems and fetal death rates (Cnattingius et al., 1998). Additionally, fetal
death rates are twice as high in mothers who are non-Hispanic black than among any other
racial/ethnic population in the United States (Barfield, 2004). A study of American Indians
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showed the highest rates of congenital anomalies regardless of fetal outcome (hydrocephalus
without spina bifida, atrial septal defect, valve stenosis and atresia, cleft palate, cleft lip, fetal
alcohol syndrome, and autosomal abnormalities excluding Down syndrome) than any other racial
or ethnic group (Chavez, Cordero, & Becerra, 1988).
Purpose of Research
The purpose of this research is to analyze the Ohio fetal death statistical files from 20062010 to determine if fetal deaths are associated with the number of prenatal visits, the mother’s
race or ethnicity, mother’s age, tobacco / alcohol use by the mother during pregnancy or other
demographic factors or risk factors during pregnancy. This study also aims to assess differences
in fetal deaths and congenital anomalies that may have developed from these risk factors.
Literature Review
Fetal death is defined as death prior to delivery of which is not an induced termination of
pregnancy (The March of Dimes Foundation, 2013). Fetal deaths encompass all deaths
occurring after 8 weeks of gestation up until birth. However, the reported fetal death rate in the
state of Ohio (and the United States) only encompasses reported deaths from 20 weeks gestation
until birth. In the past decade, the fetal death rate has decreased by 3% in the United States and
in 2006 the fetal death rate was 6 per 1,000 live births (MacDorman, Kirmeyer, & Wilson,
2012). For the state of Ohio, the fetal death rate was reported to be 6.2 per 1,000 live births,
higher than the national average at the time (MacDorman et al., 2012). The fetal death rate for
Montgomery County in 2010 was 10.2 (Public Health-Dayton & Montgomery County
[PHDMC], 2012).
Fetal mortality rate is the ratio of fetal deaths divided by the sum of live births and fetal
deaths in any given year. A nationwide study conducted by the U.S. Department of Health and
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Human Services determined that the fetal mortality rate for the state of Ohio was 4.06 per 1,000
live births in 2004-2006 (MacDorman et al., 2012). This rate is significantly less than the 2001
reported rate from the Ohio Department of Health (7.4) but falls close to the national average
(4.02) reported during this time period by the U.S. Department of Health and Human Services
study. From this study, it was determined that Ohio ranks 19th for fetal deaths in the United
States, not including US owned territories (MacDorman et al., 2012). While statistics shows that
the fetal death rate has dropped over 3% nationwide and in the state of Ohio, fetal deaths are still
expected to encompass 58% of all perinatal deaths reported in the United States (MacDorman et
al., 2012).
The issue of fetal deaths is often overlooked, despite the concern surrounding this public
health issue. This is mainly attributed to an increase in focus on infant mortality rates.
Investigation into fetal death statistics is important in order to evaluate adverse reproductive
outcomes in order to identify the factors that result in such negative outcomes. An assessment of
fetal death rate within a community can indicate high-risk populations and further the
development of risk-reducing interventions. This rate can also be a measure of the quality of
health care in a community.
Infant Mortality Rate
Infant mortality rate is a common statistic that is more frequently reported and analyzed
compared to fetal death rates. Infant mortality is of great concern because of the late
reproductive loss and is generally the primary focus (MacDorman et al., 2012). The lack of
knowledge regarding the incidence, etiology, and prevention of fetal deaths has decreased the
focus on this important statistic. Many statistical surveys focus on fetal deaths before 20 weeks
of gestation and utilize different statistical subsets such as the perinatal mortality rate which
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includes the death of a fetus from 20 weeks gestation and up to 28 weeks of life (MacDorman et
al., 2012). The infant mortality rate for Ohio in 2008 was 7.7 per 1,000 live births for the state of
Ohio and 8 per 1,000 live births in Montgomery county (Ohio Department of Health [ODH],
2010). Data for 2011 shows that the infant mortality rate for Montgomery County at 8.8 and the
state of Ohio at 7.9 per 1,000 live births (PHDMC, 2012).
Risk Factors
Extensive research has been done regarding risk factors during pregnancy and the
influences on the fetus. During the average pregnancy, the risk of fetal death is influenced by
many factors, the leading ones being maternal age, smoking habits, multiple births, and severe
pre-eclampsia (Cnattingius et al., 1998). Many of these fetal deaths are associated with
congenital anomalies. These congenital anomalies can be developed because of genetics, habits
of the mother during pregnancy, or from other health issues related to pregnancy. Some major
factors that can contribute to congenital anomalies and fetal deaths are advancing maternal age,
absence or lack in prenatal care, maternal habits (such as smoking or alcohol use), and maternal
race / ethnicity. The following sections describe the roles that these factors (and others) play
during pregnancy, development of the fetus, and ultimately, fetal viability.
Advancing maternal age.
Over the past decades, women have become increasingly involved in the work force and
continuing education. Now, women are more likely to put off having a family to focus on
educational and career goals. As a result, the age of first births among women has increased and
the rate of these births among women 40 years of age or older has doubled (Fretts et al., 1995).
A 30-year long study by Fretts, Schmittdiel, McLean, Usher, and Goldman (1995) indicates that
women who are 35 years of age or older had an increased incidence of multiple gestations,
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hypertension, diabetes mellitus, placenta previa, placental abruption, previous abortion and
previous fetal death. The higher prevalence of these conditions among this age subset indicates a
probable correlation between maternal age and the increased fetal death rate. Advancing
maternal age also has been proven to increase the risk of stillbirth or miscarriage in fetuses that
are younger than 13 weeks gestation (Nicolaides, 2011). The U.S. Department of Health and
Human Services also found that fetal death rates varied greatly by maternal age. Women who
were 45 years and over had a fetal mortality rate of 13% while women between the ages of 30
and 34 had the lowest fetal mortality rate at 5.4% (MacDorman et al., 2012). After the age of 35,
the fetal mortality rate steadily increases among women, independent of their race. Besides
advancing maternal age, a lack of prenatal care plays a role in possible development of
congenital problems in the fetus.
Prenatal care.
Prenatal care plays an important role in a healthy pregnancy, successful delivery, and life
of the newborn. It is expected that for each mother-baby couplet that enters a hospital, those
who did not receive adequate prenatal care will incur double the health care expenditures than
couplets that entered a prenatal care program early into the pregnancy (Moore, Origel, Key, &
Resnik, 1986). Research by Moore, Origel, Key, and Resnik (1986) showed that “no care”
pregnancies were 11% more likely to deliver preterm, 15% more likely to deliver low birth
weight babies, and 14% more likely to be admitted to the intensive care unit. This study also
showed that about 4% of the “no care” pregnancies ended in fetal demise, most often related to
placental abruption, maternal hypertension, and premature labor. A more recent study has
revisited this research and found that preterm birth is the most frequent cause (70%) of fetal
death in the United States (Vintzileos, Ananth, Smulian, Scorza, & Knuppel, 2002).
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Prenatal care has also been shown to decrease the risk of preterm birth and fetal demise in
pregnancies that are considered high-risk, regardless of the maternal race (Vintzileos et al.,
2002). A study by Vintzileos, Ananth, Smulian, Scorza, and Knuppel (2002) concluded that a
lack of prenatal care was associated with an increased relative risk of 2.8 for preterm birth in
both African American and White women. Up until the 1990’s, requirements for appropriate
prenatal care received very little attention (Racine, Joyce, & Grossman, 1992). With the
initiative to improve infant outcomes, standard guidelines for prenatal care were created by
recommendations from the American College of Obstetricians and Gynecologists. These
recommendations included early and continuous risk assessment, health promotion, and
medical/psychological interventions (Racine et al., 1992). Also emphasized is beginning
prenatal care as early as possible during the first trimester, as well as continuing to have 13-15
prenatal visits over the course of a normal pregnancy. Joyce and Grossman (1990) determined
that the interval between the date of a woman’s last menstrual period and their first prenatal visit
varied depending on insurance status and race. In 1984 (New York City), Caucasian women
over 20 years of age took three months to have their first prenatal visit, if they had health
insurance, while women without health insurance took almost four months to have their first
prenatal visit. Additionally, African American women in this study took over four months to
have their first visit (with insurance) and over six months without insurance (Joyce & Grossman,
1990). This variability in prenatal care has drastically decreased with more information available
to first time mothers and standards for prenatal care. Despite these standards, many women still
choose to hold off beginning their prenatal care visits for insurance and financial reasons.
Prenatal care has proven to increase the health and viability of a fetus primarily because prenatal
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visits have historically been a significant determinant of birth weight and birth weight has proven
to be a key factor in infant survival and overall health (Donaldson & Billy, 1984).
Maternal race.
High-risk pregnancies can occur among all races and ethnicities, however, many African
American mothers are having difficult pregnancies and negative fetal outcomes. It has been
found that African American mothers are most likely to develop gestational diabetes during
pregnancy than any other maternal race (Schaefer-Graf et al., 2000). Studies have also shown
that pregnancies can be greatly complicated by Diabetes Mellitus and gestational diabetes as
infants of diabetic mothers have increased incidence of congenital anomalies, accounting for half
of the perinatal mortality rates in a 1970’s study (Pedersen & Molsted-Pedersen, 1981).
Hyperglycemia (increased blood sugar levels) during the development of an embryo has been
linked to birth defects and anomalies of the central nervous system, heart, vessels, kidneys, and
axial skeleton (Schaefer-Graf et al., 2000). This risk for having an infant with an anomaly is
associated with maternal hyperglycemia detected at the entry into prenatal care. Results from a
study by Schaefer-Graf et al. (2000) have concluded that about 9.5% of births associated with
maternal diabetes will result in an anomalous infant. While diabetes is a marked contributor to
congenital anomalies among African Americans, other races are also affected by maternal and
fetal complications related to this disease.
The Centers for Disease Control and Prevention have broken down the prevalence of
congenital anomalies in different racial or ethnic groupings from a sample of over 4.6 million
births. This report indicates that American Indians had the highest total rate of anomalies
including hydrocephalus, atrial septal defect, valve stenosis, cleft palate/lip, rectal atresia, fetal
alcohol syndrome and autosomal abnormalities excluding Down syndrome (Chavez et al., 1988).
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Caucasians had the next highest rate of anomalies including clubfoot, hip dislocation, and
hypospadias. Chavez, Cordero, and Becerra (1988) continues the report by concluding that:
Rates for microcephalus, patent ductus arteriosus and pulmonary artery stenosis were
highest among African Americans. The highest rates of anencephaly, spina bifida without
anencephaly, and Down syndrome occurred among Hispanics. The rates for two major
birth defects — anencephaly and ventricular septal defect — were highest among Asians.
(p.19)
Along with the increase incidence of congenital anomalies among different ethnicities, the 2012
report by the U.S. Department of Health and Human Services concludes that from 2005 – 2006,
“fetal mortality rates declined 4% for non-Hispanic black women, while rates for other racial and
ethnic groups were essentially unchanged” (MacDorman et al., 2012, p. 10). Regardless of these
findings, the fetal mortality rate for non-Hispanic black women (10.73) was more than twice the
rate for non-Hispanic white women (4.81) in 2006 (MacDorman et al., 2012). According to this
article, part of the high fetal mortality among non-Hispanic black women relates to their higher
risk for preterm delivery. The etiology of this risk for preterm delivery is unknown among the
non-Hispanic black population, but from both of these reports, it can be concluded that race
plays a role not only in the development of congenital anomalies among fetuses, but race also
plays a role in fetal deaths, pregnancy complications, and birth weight.
Maternal substance use.
Substance abuse during pregnancy has proven to be statistically significant in causing
difficulties during pregnancy, minor anomalies among live birth infants, and fetal deaths during
gestation (Schaefer-Graf et al., 2000). Many substances can lead to fetal anomalies and fetal
deaths. Tobacco and alcohol use are the most common and typically reported, however, illicit
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drug use typically goes unreported during the prenatal period, especially in areas where drug use
is prevalent. Because illicit drug use goes unreported, statistics involving drug use and the
contribution to fetal deaths and congenital anomalies are inaccurate when available. Illicit drug
use during pregnancy has proven to contribute greatly to congenital anomalies and fetal deaths.
The use of these substances during pregnancy is harmful to the fetus and the health of the
mother. Many fetal outcomes from tobacco and alcohol use during pregnancy are associated
with developmental delays and poor fetal growth, identified after birth. It has also been assumed
that caffeine plays a role in negative pregnancy outcomes, but a structured review by Marilyn L.
Browne (2006) has proven that caffeine does not play a statistically significant role in
contributing to these types of fetal outcomes.
Cigarette use is most the most common type of substance that is reported during
pregnancy (12%). It was concluded by Cnattingius et al. (1998) that the odds of a late fetal death
among women who smoked at least a ½ pack a day is 1.7. This study shows that smoking during
pregnancy not only increases the risk of fetal death, but also increases the risk of maternal
complications such as uterine or placental insufficiency. These complications can have serious
outcomes leading to premature birth of the infant or maternal hemorrhage. Many infants who
survive during this type of pregnancy are born with a nicotine addiction that is difficult to control
post-partum (Ricci & Kyle, 2009). Among all mothers who experienced a stillbirth (fetal death
late in gestation), 34% smoked and 21% both consumed alcohol and smoked before and during
their pregnancy (Prager, Malin, Spiegler, Van Natta, & Placek, 1984). However, of all the live
births recorded in a study by Prager, Malin, Spiegler, Van Natta, and Placek (1984), 35% of the
mothers smoked during pregnancy and 55% consumed alcohol during pregnancy. Since this
1980’s study was conducted, the percentage of mothers who smoke and/or drink during
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pregnancy has drastically declined with publically available health information, higher educated
mothers (at least high school graduates), and proper prenatal care.
A study by Karin Källén (1999) found a statistically significant correlation between
maternal smoking and congenital heart defects. The exact teratogenic effect of tobacco is
uncertain, but positive associations between maternal smoking and heart defects, oral clefts, limb
defects and kidney malformations have been reported (Källén, 1999). This study showed that the
odds ratio of having a fetal heart defect was as high as 1.63 among the studied population of
women who smoked. It is important to consider maternal smoking rates when looking at fetal
death statistics as many congenital anomalies and developmental issues can be attributed to
tobacco use, but the evidence to prove this association is slim. A primary problem with drawing
associations between tobacco use and fetal anomalies is similar to the conclusions drawn by
Prager et al. (1984). Much of the existing data can prove that women who smoke have babies
that are stillborn or babies born with defects, but additionally, an equal or greater percentage of
women who do not smoke have babies who are still born or babies born with defects. The
evidence linking smoking to negative pregnancy outcomes is a primary focus of this project is to
determine if there are statistically significant associations between maternal smoking habits and
fetal deaths from congenital anomalies.
Alcohol consumption during pregnancy has also led to the development of fetal defects.
The neural tube fully develops within the first 1-2 months after conception and many women do
not find out they are pregnant until it is fully developed (about 8 weeks along). Because of this,
fetal defects affecting the neural tube due to alcohol use can occur before a mother is aware of
the pregnancy (Ricci & Kyle, 2009). Fetal exposure to alcohol is also a primary cause of other
congenital anomalies of the heart and organs along with mental retardation (Penchaszadeh,
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2002). Fetal alcohol syndrome can be associated with any adverse reproductive outcomes that
could result from chronic consumption of alcohol during pregnancy (Windham, Fenster, &
Swan, 1992). In addition to alcohol consumption, the prevalence of fetal alcohol syndrome has
also been correlated with maternal low educational level and smoking (Penchaszadeh, 2002). A
study from Oklahoma (cited by Windham et al., 1992) found that consuming one to two drinks
per day can double the risk for fetal death and three or more drinks a day can increase the
relative risk for fetal death to 3.5. Contrary to the Oklahoma study, Windham, Fenster, and
Swan (1992) concluded that 27% of still births were to mothers consuming 1-3 drinks per week
and 25% of live births were to mothers consuming 1-3 drinks per week. Only a 2% difference
separated the two groups (live births and still births) and it was concluded that there is not a
significant risk for spontaneous abortion or fetal death with alcohol consumption before
pregnancy or occasional drinking during pregnancy (Windham et al., 1992). An association
between alcohol consumption and fetal death has been found in other studies, but not all. Many
do not take into account confounding variables such as smoking, second-hand smoke, or lack of
prenatal care which can affect the data regarding fetal deaths. While a great deal of information
is available linking alcohol to birth defects, the amount that needs to be consumed during
pregnancy to produce these effects is unknown and varies depending on a variety of factors such
as genetics, maternal age and health issues (Windham et al., 1992).
Pesticides, medications, and chemicals.
Many experimental studies have been conducted using laboratory animals to analyze the
effects of pesticides and medications on reproductive outcomes (Bell, Hertz-Picciotto, &
Beaumont, 2001). A 2001 study by Bell et al. applied this information to a study of residential
proximity to pesticides in relation to fetal deaths due to congenital anomalies. This study
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identified 10 California counties based on their location to areas of high pesticide usage. Bell et
al. (2001) used fetal death records, birth and death certificates, as well as a self-administered
questionnaire to conduct their study. By analyzing maternal data for the date of the mother’s last
menstrual period and categorizing women based on their residence in relation to pesticide use, it
was determined that close proximity to commercial pesticide applications caused an increased
risk of fetal deaths due to congenital anomalies. Over 327 different pesticides were used within
the set counties and several of these pesticides were linked with fetal deaths due to congenital
anomalies when exposure occurred during the 3rd-8th weeks of pregnancy (Bell et al., 2001).
While this study was unable to specify which classes of pesticides contributed to the congenital
anomalies, it was determined that the highest risk for fetal deaths were among those individuals
living within the same square mile as the pesticide application.
In addition to pesticides, medications taken during the prenatal period can have negative
outcomes on fetal viability. Over half of the pregnancies in North America are unplanned, thus
every year hundreds of thousands of women expose their fetuses to medications before they even
know they are pregnant (Koren, Pastuszak, & Ito, 1998). A growing reason that medications are
taken prior to pregnancy is that the maternal age of many pregnant women has begun to increase.
Conditions that necessitate long-term drug therapy are diagnosed in larger numbers of women
before pregnancy (Koren et al., 1998). Many medications, prescription and over the counter, are
considered teratogenic. These types of medications can cause a dysgenesis of fetal organs and
typical manifestations of teratogenesis include restricted fetal growth, death, carcinogenesis and
congenital malformations. Most drugs are not labeled for use during pregnancy, primarily
because the manufacturer almost never tests the product in pregnant women to determine its
effects on the fetus (Koren et al., 1998). Because many drugs have not been tested as teratogens,
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the effects the medications will have on a fetus are unknown until birth or spontaneous abortion.
Very few teratogens have known effects on fetal development, but anomalies of the teeth, bones,
limbs and neural tube are common along with cardiovascular defects.
Occupational exposure to industrial chemicals during early pregnancy has also been
proven to cause neurotoxicity and other neural tube defects among developing fetuses (Julvez &
Grandjean, 2009). Since the neural tube develops fully before many women know they are
pregnant, harmful exposure to industrial chemicals can occur in a crucial time of fetal
development. Later in fetal development, a mature placenta can provide some protection against
substances but strong pesticides, solvents, or metals such as lead and mercury, can cross the
placenta in higher concentrations than expected to affect the mother (Julvez & Grandjean, 2009).
The fetal blood-brain barrier does not provide adequate protection against substances and
detoxification mechanisms are still immature. The fragile nature of a fetus creates vulnerability
during pregnancy that can lead to congenital anomalies and other birth defects. Many of these
birth defects lead to fetal deaths that can be prevented by avoiding exposure to harmful
substances.
Congenital Anomalies
In the late 1990’s, congenital anomalies accounted for about 495,000 deaths worldwide, a
majority of which occurred before birth or during the first year of life (Rosano, Botto, Botting, &
Mastroiacovo, 2000). As of 2008, the World Health Organization estimates that 260,000
neonatal deaths worldwide are caused by congenital anomalies (World Health Organization,
2009). According to an almost 50 year study conducted by Rosano, Botto, Botting, and
Mastroiacovo (2000), the impact that congenital anomalies have on fetal demise is dependent on
the prevalence of the anomaly, other competing causes of death, availability of medical care, and
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the effectiveness of primary prevention, such as prenatal care. As of 1994, anomalies of the
heart and central nervous system accounted for a combined total of 44% of infant deaths in the
United States (Rosano et al., 2000). Other types of congenital anomalies can include structural
birth defects or functional birth defects. Structural birth defects are related to physical problems
with body parts, including cleft lip or cleft palate, club foot, and spina bifida (MedicineNet.com,
2008). These types of birth defects are related to the growth and development of a fetus,
whereas functional birth defects are related to how a body system works, typically leading to
disabilities. Types of functional birth defects can include: Down syndrome, blindness, deafness,
phenylketonuria (PKU), or muscular dystrophy (MedicineNet.com, 2008). Many fetuses with
one congenital anomaly will have other developmental issues causing a combination of structural
and functional defects. Extensive research has been done linking Folic Acid deficiency to neural
tube defects such as spina bifida and anencephaly. It is expected that these defects affect over
4000 pregnancies annually, 25% ending in fetal demise (Honein, Paulozzi, Mathews, Erickson,
& Wong, 2001). These defects can develop quite early in pregnancy, sometimes before a woman
even knows she is carrying a baby. It has been proven by Honein, Paulozzi, Mathews, Erickson,
and Wong (2001), that folic acid supplementation before conception and during the prenatal
period can be 100% protective against neural tube defects.
Many anatomical birth defects can be detected during a prenatal ultrasound. Early
detection of a congenital anomaly can influence the plan of care for the fetus during the prenatal
period (We, Young, Park, Shin, & Im, 2012). However, despite the technology available for
pregnant women, many fetal deaths are unexpected. The public health issue of fetal deaths
continues to be significant, yet much of the details behind the etiology of fetal deaths are
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unknown. This research aims to find correlations between the occurrences of congenital
anomalies related to fetal deaths in the State of Ohio from 2010 data.
Methods
Through further research and statistical analysis, this study aims to build upon the
literature review by studying probable associations between congenital anomalies and the
aforementioned pregnancy risk factors and maternal demographics. Fetal death data from the
state of Ohio, 2006-2010, had been previously obtained and deidentified before use during this
project. Approval from the Wright State University Institutional Review Board (IRB) was
obtained to use this data (Appendix A) and the author received the required ethics training
(Appendix B). The information in the statistical files was defined and arranged in a Microsoft
Excel spreadsheet to be filtered and sorted. An analysis of the fetal death files was conducted to
first isolate fetal deaths based on congenital anomalies. Of the twenty congenital anomalies
reported in the fetal death files, six major categories for the various types of anomalies were
created (Table 1). From this new data set, factors relating to the mother (see also Table 2) are
used to determine statistical significance in contributing to the development of congenital
anomalies and ultimately, the death of the fetus. A description of the variables used in this
analysis is found in Table 3. The data was analyzed according to whether the fetal death
occurred with or without the presence of a congenital anomaly. A Chi-Square analysis was
conducted to determine statistical differences between fetal populations based on maternal
demographics. All statistical analysis was performed using the Microsoft Excel program.

FETAL DEATHS AND CONGENITAL ANOMALIES
Table 1
Congenital Anomalies of the Fetus, Arranged by Category
Categories of Congenital Anomalies
Musculoskeletal
Cleft Lip/Palate
Polydactyly/Syndactyly/Adactyly
Club Foot
Diaphragmatic Hernia
Other Musculoskeletal/Integumental Anomalies
Heart/Circulation
Heart Malformations
Other Circulatory Anomalies
Nervous System
Anencephalus
Spina Bifida/Meningocele
Hydrocephalus
Microcephalus
Other Central Nervous System Anomalies
Gastrointestinal/Urogenital
Rectal Atresia/Stenosis
Tracheo-Esophageal Fistula/Esophageal Atresia
Omphalocele/Gastroschisis
Malformed Genitalia
Renal Agenesis
Other Gastrointestinal Anomalies
Other Urogenital Anomalies
Chromosomal
Down’s Syndrome
Other Chromosomal Anomalies
Other

20
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Table 2
Maternal Demographics and Risk Factors obtained from the Preexisting Data Set for use in
Statistical Analysis
Characteristic
Sex of Fetus
Date of Delivery
Mother’s Age (Years)
Month/Year Date of Mother’s Last Live Birth
Month/Year Date of Mother’s Last Other Termination
Plurality
Medical Risk Factors for this Pregnancy
Tobacco Use
Alcohol Use
Weight Gain during Pregnancy (lbs)
Obstetric Procedures
Complications of Labor and Delivery
Method of Delivery
Congenital Anomalies of the Fetus
Hispanic Ethnicity
Race Education of the Mother
Number of Previous Births Now Living
Number of Previous Births Now Dead
Number of Other Terminations
Prenatal Care History
Weight of Fetus
Clinical Estimation of Gestation
Primary Underlying Cause of Fetal Death
Data Year
Table 3
Variables used for Data Analysis
Variable

Measure

Dependency

Fetal Deaths

The number of deaths of a fetus between
8 weeks gestation and birth

Dependent

Congenital Anomalies
(with respect to maternal
and prenatal risk factors)

The number of infants born with one or
more congenital anomaly

Dependent

Maternal and Prenatal
Risk Factors

Any statistically significant risk factor that Independent
negatively affects the fetal outcome (age,
race, APNCU)
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Results
The number of fetal deaths decreased by 10 percent from 2006 to 2010 (Table 4). Many
factors significantly contributed to the fetal death rate including maternal age, prenatal care,
maternal race, and the presence of a congenital anomaly.
Table 4
Number of Reported Fetal Deaths by year, 2006-2010, in the State of Ohio
Fetal Deaths
(N = 4,622)
Characteristic

n

%

965
956
914
917
870

20.9
20.7
19.8
19.8
18.8

Year
2006
2007
2008
2009
2010

Note: All totals are un-weighted.

Table 5 illustrates the maternal demographic characteristics that were analyzed in this
project. Using a Chi-Square analysis, it was determined that age, race and prenatal care history
have a statistically significant (p < 0.05) difference in proportions between women who
experienced a fetal death related to a congenital anomaly and those in which no anomaly was
reported. It can also be noted from this data that women over the age of 35 were more likely to
experience a fetal death related to the presence of a congenital anomaly than women who were
under the age of 35.
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Table 5
Demographic Characteristics of Women who Experienced a Fetal Death Related to the Presence
of a Congenital Anomaly
No Anomaly
(N = 3,195)
Characteristic
Age (years)*
< 15
15 – 19
20 – 34
35 – 44*
45 +
Unknown
Education
Less than H.S.
H.S. Graduate
Some College
College Graduate
Unknown
Marital Status
Married
Not Married
Unknown
Race*
White*
African American
Other
Ethnicity
Non-Hispanic
Hispanic
Unknown
Prenatal Care*ǂ
Adequate
Intermediate
Inadequate
No Care
Unknown

Anomaly Noted
(N = 1,030)

Unknown
(N = 397)

n

%

n

%

n

%

8
402
2299
461
5
20

0.3
12.6
72.0
14.4
0.2
0.6

3
108
729
180
4
6

0.3
10.5
70.8
17.5
0.4
0.6

1
54
277
60
1
4

0.3
13.6
69.8
15.1
0.3
1.0

583
1183
660
570
199

18.2
37.0
20.7
17.8
6.2

149
383
198
233
67

14.5
37.2
19.2
22.6
6.5

74
119
84
85
35

18.6
30.0
21.2
21.4
8.8

1643
1483
69

51.4
46.4
2.2

610
391
29

59.2
38.0
2.8

215
159
23

54.2
40.1
5.8

2097
1041
57

65.6
32.6
1.8

791
217
22

76.8
21.1
2.1

294
94
9

74.1
23.7
2.3

3036 95.0
133
4.2
26
0.8

980
40
10

95.1
3.9
1.0

367
16
14

92.4
4.0
3.5

224
473
1994
157
347

82
163
640
30
115

8.0
15.8
62.1
2.9
11.2

43
44
222
15
73

10.8
11.1
55.9
3.8
18.4

7.0
14.8
62.4
4.9
10.9

Note: All totals are un-weighted.
* The difference in proportions had a statistical significance of p < 0.05.
ǂ Adequacy of prenatal care was determined using the Adequacey of Prenatal Care Utilization (APNCU) Index
(Alexander & Kotelchuck, 2001). This index categorizes care as adequate, intermediate or inadequate. It does not
assess the quality of care, only utilization. (Graeber, Phillips, Saadi, & Sommer, 2002)
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Adequacy of prenatal care, determined by the Adequace of Prenatal Care Utilization
(APNCU) index (Alexander & Kotelchuck, 2001) was also proven to have a statistical
significance. From the data analyzed in Table 5, it was noted that women who received
intermediate to adequate prenatal care had a higher percentage of fetal deaths related to
congenital anomalies than fetal deaths in which no anomaly was present. It can be determined
from this information that women who are aware of congenital anomalies or other fetal problems
during pregnancy attended more prenatal care visits than other pregnant women in this data set.
Additionally, fetal death rates (independent of the presence of a congenital anomaly) increased as
the number of prenatal care visits attended by the mother decreased. Inadequate prenatal care
was associated with over 62% of the fetal deaths in which no anomaly was present as well as
fetal deaths in which at least one congenital anomaly was noted.
Race also played a statistically significant role in this study. In general, white women
experienced a higher rate of fetal deaths related to congenital anomalies than African American
women. African American women actually experienced a lower rate of congenital anomalies in
all categories significant in this study (Table 6 and Figure 1). Statistically significant congenital
anomalies included: circulatory anomalies (including malformations of the heart), anomalies of
the nervous system and brain, and chromosomal anomalies. Anomalies that did not fit into the
categories illustrated in Table 3 were considered as “other.” There was a statistical significance
within this category between maternal races, though the exact types of anomalies included in this
subset were not reported in the data set.
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Table 6
Classification of Congenital Anomalies by Maternal Race
White
(N = 3,182)
Classification
Congenital Anomaly
Musculoskeletal
Heart/Circulation*
Nervous System*
Gastrointestinal/
Urogenital
Chromosomal*
Other*
No anomaly
Unknown

African American
(N = 1,352)

Other
(N = 88)

n

%

n

%

n

%

72
107
158

2.3
3.4
5.0

23
21
35

1.7
1.6
2.6

2
2
5

2.3
2.3
5.7

82
74
298
2097
294

2.6
2.3
9.4
65.9
9.2

28
17
93
1041
94

2.1
1.3
6.9
77.0
7.0

--4
9
57
9

4.5
10.2
64.8
10.2

Note: All totals are un-weighted.
* The difference in proportions had a statistical significance of p < 0.05.

Figure 1. Percent of congenital anomalies by maternal race. This graph shows the percent of
statistically significant congenital anomalies among White and African American females who
experienced a fetal death in Ohio (2006-2010).
Many maternal health risks and behaviors have been researched as contributing factors to
fetal deaths and the development of congenital anomalies. In this study, however, the

FETAL DEATHS AND CONGENITAL ANOMALIES

26

development of congenital anomalies could not be significantly associated with Hispanic
ethnicity, maternal education, use of tobacco or consumption of alcohol during pregnancy, or
detrimental maternal health risks such as diabetes (Tables 5 and 7).
Table 7
Maternal Health Risk Factors and Behaviors of Women who Experienced a Fetal Death Related
to the Presence of a Congenital Anomaly
No Anomaly
(N = 3,195)
Characteristic
Health Risks
Anemia
Diabetes
Oligo/Polyhydramnios
Hypertension
Incompetent Cervix
Previous Preterm/SGA
Other
No Risks
Unknown
Tobacco Use (cigarettes/day)
1 – 10
11 – 20
21 +
No tobacco use
Unknown
Alcohol Consumption (drinks/day)
1–2
3+
No alcohol use
Unknown

Anomaly Noted
(N = 1,030)

Unknown
(N = 397)

n

%

n

%

n

%

156
196
131
227
105
120
637
1556
67

4.9
6.1
4.1
7.1
3.3
3.8
19.9
48.7
2.1

31
63
62
42
7
26
251
506
42

3.0
6.1
6.0
4.1
0.7
2.5
24.4
49.1
4.1

9
16
11
21
17
14
64
76
169

2.3
4.0
2.8
5.3
4.3
3.5
16.1
19.4
42.6

383
116
36
926
1734

12.0
3.6
1.1
29.0
54.3

129
33
5
317
546

12.5
3.2
0.5
30.1
53.0

36
9
6
58
288

9.1
2.3
1.5
14.9
72.5

26
54
2890
225

0.8
1.7
90.5
7.0

3
18
924
85

0.3
1.7
89.7
8.3

2
3
286
106

0.5
0.8
72.0
26.7

Note: All totals are un-weighted.

Discussion
This study aimed to find significant associations between women who experienced a fetal
death related to the presence of a congenital anomaly and maternal factors that might contribute
to negative fetal outcomes. As discussed in the literature review, there is scientific evidence that
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associates many maternal factors with fetal outcomes. Factors such as maternal race, ethnicity,
age, education and prenatal care all have been shown to effect a fetus’ development and
contribute to the development of congenital anomalies (Cnattingius et al., 1998). Maternal
behaviors such as tobacco use and alcohol consumption during pregnancy have also proven to
have negative fetal outcomes (Schaefer-Graf et al., 2000). The results of this study showed
statistical significance between populations of women who experienced a fetal death with and
without the presence of a congenital anomaly. What was proven during this analysis, however,
was only that age, race, and the number of prenatal care visits had a statistically significant effect
on the fetal outcomes.
Our investigation concluded that women who were over the age of 35 had a 3.3 percent
higher rate of congenital anomalies compared to all other age groups in our data set. This
reflects the research presented in the literature review by Fretts et al. (1995) which indicated that
women over the age of 35 were more likely to experience complications during pregnancy and
an increased rate of fetal demise. The significance in our data indicates that known trends
relating maternal age to fetal outcomes also applies to our data set.
The 2004 Minority Health Profile published by the Ohio Department of Health (ODH)
states that “congenital malformations were the second-leading cause of death in black infants
from 1999-2001 at 11.4% (ODH, 2004, p.5). The ODH (2004) also reports that the fetal death
rate for blacks was nearly twice the rate for whites from 1993-2001 in the state of Ohio.
However, our data set (2006-2010) shows that over 2.4 times the fetal deaths reported were
among White women compared to African Americans. Much of this was expected as White
women contributed to 68.8% of the reported population. Our analysis did however indicate that
there was statistical significance regarding the increased percentage of fetal deaths related to
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congenital anomalies observed within the White population. Among White women, 24.9 percent
had a fetal death related to a congenital anomaly and only 16.1 percent of African American
women had a fetal death related to the presence of an anomaly.
Prenatal care can help with fetal development during pregnancy and it can be a way of
tracking changes or abnormalities in fetal growth. The results of this study did not indicate that a
lack of prenatal care had any contribution to negative fetal outcomes or the development of a
congenital anomaly. This is contrary to what was expected, as results of previous studies have
revealed that inadequate prenatal care can have a significant impact on fetal development and
neural function.
Conclusion
The data analyzed in this study showed that only a few key points bore any statistical
significance. From this information, we can conclude that the state of Ohio follows many of the
general trends related to fetal deaths reported in the literature review. An interesting finding was
that the minority populations did not have higher percentages of fetal deaths from congenital
anomalies, rather, White women held the largest percentage in this category. One major
weakness of this study was that while there is an abundance of literature available to prove that
maternal behaviors such as smoking and alcohol consumption during pregnancy have a negative
effect on fetal outcomes, our research showed no statistical significance to prove this point.
There was no clear association between poor maternal choices during pregnancy and the
development of a congenital anomaly. Some additional limitations to this study involving our
data set centers around missing and inaccurate data. There is a self-reporting bias which could
have contributed to lower smoking and alcohol consumption rates as well as falsely inflated
prenatal care visits. Additionally, almost nine percent of the data had an unknown congenital
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anomaly history which makes it difficult to place this group in a specific category. Finally, many
early fetal deaths go unreported, so it is expected that a percentage of fetal deaths that may have
occurred were not reported in our data set.
Doing further research to take a look at important factors that were unreported in this data
set could expand this study. Socioeconomic status, health insurance, and availability of health
care resources are three key factors that could be explored to help see the impact of prenatal care
on fetal outcomes in the state of Ohio. Additionally, a further analysis of congenital anomalies
could be conducted within a bigger data set. Congenital anomalies only played a role in 22.3%
of the fetal deaths reported in this data set. A larger data set would provide a sample size with
more occurrences of congenital anomalies as well as an opportunity to compare trends in
congenital anomalies over longer periods of time. A final aspect of this study which could be
expanded is the maternal information collected. Research has proven that folic acid is crucial
during the prenatal period for neurological development of the fetus. This data set did not
provide information about prenatal supplements or maternal diet, however, an expansion on this
aspect of the study could help assess the effect of prenatal care in the state of Ohio on fetal
development and prevalence of congenital anomalies. The results obtained in this study suggest
the need for continued research and investigation to better understand how great of an impact
congenital anomalies have on fetal demise.
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Appendix C: List of Tier 1 Core Public Health Competencies Met
Domain #1: Analytic/Assessment
Identify the health status of populations and their related determinants of health and illness (e.g., factors
contributing to health promotion and disease prevention, the quality, availability and use of health services)
Describe the characteristics of a population-based health problem (e.g., equity, social determinants,
environment)
Use variables that measure public health conditions
Use methods and instruments for collecting valid and reliable quantitative and qualitative data
Identify sources of public health data and information
Recognize the integrity and comparability of data
Identify gaps in data sources
Adhere to ethical principles in the collection, maintenance, use, and dissemination of data and information
Describe the public health applications of quantitative and qualitative data
Collect quantitative and qualitative community data (e.g., risks and benefits to the community, health and
resource needs)
Use information technology to collect, store, and retrieve data
Describe how data are used to address scientific, political, ethical, and social public health issues
Domain #2: Policy Development and Program Planning
Gather information relevant to specific public health policy issues
Describe how policy options can influence public health programs
Describe the public health laws and regulations governing public health programs
Participate in program planning processes
Incorporate policies and procedures into program plans and structures
Identify mechanisms to monitor and evaluate programs for their effectiveness and quality
Demonstrate the use of public health informatics practices and procedures (e.g., use of information systems
infrastructure to improve health outcomes)
Apply strategies for continuous quality improvement
Domain #3: Communication
Identify the health literacy of populations served
Communicate in writing and orally, in person, and through electronic means, with linguistic and cultural
proficiency
Solicit community-based input from individuals and organizations
Convey public health information using a variety of approaches (e.g., social networks, media, blogs)
Participate in the development of demographic, statistical, programmatic and scientific presentations
Apply communication and group dynamic strategies (e.g., principled negotiation, conflict resolution, active
listening, risk communication) in interactions with individuals and groups
Domain #4: Cultural Competency
Incorporate strategies for interacting with persons from diverse backgrounds (e.g., cultural, socioeconomic,
educational, racial, gender, age, ethnic, sexual orientation, professional, religious affiliation, mental and
physical capabilities)
Recognize the role of cultural, social, and behavioral factors in the accessibility, availability, acceptability
and delivery of public health services
Respond to diverse needs that are the result of cultural differences
Describe the dynamic forces that contribute to cultural diversity
Describe the need for a diverse public health workforce
Domain #5: Community Dimensions of Practice – N/A

Used
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Domain #6:Public Health Sciences
Describe the scientific foundation of the field of public health
Identify the basic public health sciences (including, but not limited to biostatistics, epidemiology,
environmental health sciences, health services administration, and social and behavioral health sciences)
Describe the scientific evidence related to a public health issue, concern, or, intervention
Retrieve scientific evidence from a variety of text and electronic sources
Discuss the limitations of research findings (e.g., limitations of data sources, importance of observations and
interrelationships)
Partner with other public health professionals in building the scientific base of public health
Domain #7: Financial Planning and Management – N/A
Domain #8: Leadership and Systems Thinking
Incorporate ethical standards of practice as the basis of all interactions with organizations, communities, and
individuals
Describe how public health operates within a larger system
Identify internal and external problems that may affect the delivery of Essential Public Health Services
Use individual, team and organizational learning opportunities for personal and professional development
Describe the impact of changes in the public health system, and larger social, political, economic
environment on organizational practices
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